Annotation Details for NCOA1
Basic Information Top
| Gene Symbol: | NCOA1 ( F-SRC-1,KAT13A,MGC129719,MGC129720,RIP160,SRC1,bHLHe42,bHLHe74 ) |
|---|---|
| Gene Full Name: | nuclear receptor coactivator 1 |
| Band: | 2p23.3 |
| Quick Links | Entrez ID:8648; OMIM: 602691; Uniprot ID:NCOA1_HUMAN; ENSEMBL ID: ENSG00000084676; HGNC ID: 7668 |
| Relate to Another Database: | SFARIGene; denovo-db |
| GO ID | Evidence | Qualifier | GO_term | References |
|---|---|---|---|---|
| GO:0000790 | IDA | - | nuclear chromatin | 15831516 |
| GO:0005654 | IDA | - | nucleoplasm | - |
| GO:0005654 | TAS | - | nucleoplasm | - |
| GO:0005829 | IDA | - | cytosol | - |
| GO:0005886 | IDA | - | plasma membrane | - |
| GO:0043005 | IEA | - | neuron projection | - |
| GO:0043234 | IMP | - | protein complex | 15641800 |
| GO ID | Evidence | Qualifier | GO_term | References |
|---|---|---|---|---|
| GO:0001012 | IEA | - | RNA polymerase II regulatory region DNA binding | - |
| GO:0001105 | NAS | - | RNA polymerase II transcription coactivator activity | 15774904 |
| GO:0003682 | IEA | - | chromatin binding | - |
| GO:0003713 | IDA | - | transcription coactivator activity | 10207113 |
| GO:0003713 | NAS | - | transcription coactivator activity | 15572661 |
| GO:0004402 | IEA | - | histone acetyltransferase activity | - |
| GO:0005515 | IPI | - | protein binding | 9556555 |
| GO:0016922 | IPI | - | ligand-dependent nuclear receptor binding | 17363140 |
| GO:0017162 | IPI | - | aryl hydrocarbon receptor binding | 15641800 |
| GO:0019899 | IPI | - | enzyme binding | 12039952 |
| GO:0030331 | IPI | - | estrogen receptor binding | 18563714 |
| GO:0030374 | IDA | - | ligand-dependent nuclear receptor transcription coactivator activity | 15919756 |
| GO:0032403 | IEA | - | protein complex binding | - |
| GO:0033142 | IEA | - | progesterone receptor binding | - |
| GO:0035257 | IDA | - | nuclear hormone receptor binding | 10207113 |
| GO:0046965 | IEA | - | retinoid X receptor binding | - |
| GO:0046983 | IEA | - | protein dimerization activity | - |
| GO:0047485 | IPI | - | protein N-terminus binding | 12917342 |
| GO:0050681 | NAS | - | androgen receptor binding | 15572661 |
| GO ID | Evidence | Qualifier | GO_term | References |
|---|---|---|---|---|
| GO:0000435 | IDA | - | positive regulation of transcription from RNA polymerase II promoter by galactose | 10207113 |
| GO:0002155 | IEA | - | regulation of thyroid hormone mediated signaling pathway | - |
| GO:0006351 | IDA | - | transcription, DNA-templated | 9223431 |
| GO:0006366 | IEA | - | transcription from RNA polymerase II promoter | - |
| GO:0007595 | IEA | - | lactation | - |
| GO:0008584 | IEA | - | male gonad development | - |
| GO:0015721 | TAS | - | bile acid and bile salt transport | - |
| GO:0019216 | TAS | - | regulation of lipid metabolic process | - |
| GO:0021549 | IEA | - | cerebellum development | - |
| GO:0021766 | IEA | - | hippocampus development | - |
| GO:0021854 | IEA | - | hypothalamus development | - |
| GO:0021987 | IEA | - | cerebral cortex development | - |
| GO:0030521 | NAS | - | androgen receptor signaling pathway | 15572661 |
| GO:0030522 | IBA | - | intracellular receptor signaling pathway | - |
| GO:0032355 | IEA | - | response to estradiol | - |
| GO:0032526 | IEA | - | response to retinoic acid | - |
| GO:0032570 | IEA | - | response to progesterone | - |
| GO:0032870 | IBA | - | cellular response to hormone stimulus | - |
| GO:0043065 | IEA | - | positive regulation of apoptotic process | - |
| GO:0043967 | IEA | - | histone H4 acetylation | - |
| GO:0044849 | IEA | - | estrous cycle | - |
| GO:0045666 | IEA | - | positive regulation of neuron differentiation | - |
| GO:0045893 | IDA | - | positive regulation of transcription, DNA-templated | 11891224 |
| GO:0045893 | NAS | - | positive regulation of transcription, DNA-templated | 15572661 |
| GO:0045925 | IEA | - | positive regulation of female receptivity | - |
| GO:0045944 | IDA | - | positive regulation of transcription from RNA polymerase II promoter | 15919756 |
| GO:0045944 | NAS | - | positive regulation of transcription from RNA polymerase II promoter | 15774904 |
| GO:0060179 | IEA | - | male mating behavior | - |
| GO:0060713 | IEA | - | labyrinthine layer morphogenesis | - |
| GO:1904017 | IEA | - | cellular response to Thyroglobulin triiodothyronine | - |
| GO:2001038 | IEA | - | regulation of cellular response to drug | - |
| Gene Symbol | Interactant | Interaction ID | References | Description |
|---|---|---|---|---|
| NCOA1 | AR | 106862 | 10567563 12163482 15256534 | Affinity Capture-Western; Reconstituted Complex; Two-hybrid |
| NCOA1 | AR | 114200 | 10567563 12163482 15256534 | Affinity Capture-Western; Reconstituted Complex; Two-hybrid |
| NCOA1 | CCND1 | 107067 | 9832502 | Affinity Capture-Western; Reconstituted Complex |
| NCOA1 | CCND1 | 114200 | 9832502 | Affinity Capture-Western; Reconstituted Complex |
| NCOA1 | BCL3 | 107074 | 10497212 | Two-hybrid |
| NCOA1 | BCL3 | 114200 | 10497212 | Two-hybrid |
| NCOA1 | CREBBP | 114200 | 9192892 11113179 11971985 14722092 | Affinity Capture-MS; Affinity Capture-Western; Reconstituted Complex; Two-hybrid |
| NCOA1 | CREBBP | 107777 | 9192892 11113179 11971985 14722092 | Affinity Capture-MS; Affinity Capture-Western; Reconstituted Complex; Two-hybrid |
| NCOA1 | DDX5 | 108021 | 11250900 | Phenotypic Enhancement; Reconstituted Complex |
| NCOA1 | DDX5 | 114200 | 11250900 | Phenotypic Enhancement; Reconstituted Complex |
| NCOA1 | EP300 | 114200 | 14722092 | Affinity Capture-Western |
| NCOA1 | EP300 | 108347 | 14722092 | Affinity Capture-Western |
| NCOA1 | NR2F6 | 108375 | 10713182 | Reconstituted Complex |
| NCOA1 | NR2F6 | 114200 | 10713182 | Reconstituted Complex |
| NCOA1 | ESR1 | 108403 | 9192892 9192902 9259327 9427757 9773983 10598586 10760302 11003650 11113179 11250900 11358671 11867769 12574227 12714702 14715875 | Affinity Capture-Western; FRET; Phenotypic Enhancement; Reconstituted Complex; Two-hybrid |
| NCOA1 | ESR1 | 114200 | 9192892 9192902 9259327 9427757 9773983 10598586 10760302 11003650 11113179 11250900 11358671 11867769 12574227 12714702 14715875 | Affinity Capture-Western; FRET; Phenotypic Enhancement; Reconstituted Complex; Two-hybrid |
| NCOA1 | ESR2 | 114200 | 10809226 11500849 14715875 | Affinity Capture-Western; FRET; Two-hybrid |
| NCOA1 | ESR2 | 108404 | 10809226 11500849 14715875 | Affinity Capture-Western; FRET; Two-hybrid |
| NCOA1 | ESRRG | 114200 | 11864604 | Reconstituted Complex |
| NCOA1 | ESRRG | 108407 | 11864604 | Reconstituted Complex |
| NCOA1 | FOS | 108636 | 9642216 10847592 18511550 | Affinity Capture-Western; Reconstituted Complex; Two-hybrid |
| NCOA1 | FOS | 114200 | 9642216 10847592 18511550 | Affinity Capture-Western; Reconstituted Complex; Two-hybrid |
| NCOA1 | NR5A1 | 108792 | 9328345 | Two-hybrid |
| NCOA1 | NR5A1 | 114200 | 9328345 | Two-hybrid |
| NCOA1 | NR3C1 | 109165 | 9590696 10659697 11266503 12118039 | Affinity Capture-Western; Reconstituted Complex; Two-hybrid |
| NCOA1 | NR3C1 | 114200 | 9590696 10659697 11266503 12118039 | Affinity Capture-Western; Reconstituted Complex; Two-hybrid |
| NCOA1 | GTF2B | 109214 | 8754792 | Reconstituted Complex |
| NCOA1 | GTF2B | 114200 | 8754792 | Reconstituted Complex |
| NCOA1 | HIF1A | 109338 | 10594042 | Reconstituted Complex |
| NCOA1 | HIF1A | 114200 | 10594042 | Reconstituted Complex |
| NCOA1 | NR4A1 | 109407 | 12082103 | Reconstituted Complex |
| NCOA1 | NR4A1 | 114200 | 12082103 | Reconstituted Complex |
| NCOA1 | FOXA2 | 109412 | 11069927 | Two-hybrid |
| NCOA1 | FOXA2 | 114200 | 11069927 | Two-hybrid |
| NCOA1 | HNF4A | 109414 | 9812974 | Two-hybrid |
| NCOA1 | HNF4A | 114200 | 9812974 | Two-hybrid |
| NCOA1 | PRMT1 | 109512 | 11050077 | Reconstituted Complex |
| NCOA1 | PRMT1 | 114200 | 11050077 | Reconstituted Complex |
| NCOA1 | JUN | 109928 | 9642216 10567404 10847592 | Reconstituted Complex; Two-hybrid |
| NCOA1 | JUN | 114200 | 9642216 10567404 10847592 | Reconstituted Complex; Two-hybrid |
| NCOA1 | CIITA | 110416 | 12933903 | Affinity Capture-Western; Reconstituted Complex |
| NCOA1 | CIITA | 114200 | 12933903 | Affinity Capture-Western; Reconstituted Complex |
| NCOA1 | NFKB1 | 110857 | 9556555 10847592 | Reconstituted Complex |
| NCOA1 | NFKB1 | 114200 | 9556555 10847592 | Reconstituted Complex |
| NCOA1 | PGR | 111260 | 12529333 | Two-hybrid |
| NCOA1 | PGR | 114200 | 12529333 | Two-hybrid |
| NCOA1 | PPARA | 114200 | 9407140 9626662 | Reconstituted Complex; Two-hybrid |
| NCOA1 | PPARA | 111461 | 9407140 9626662 | Reconstituted Complex; Two-hybrid |
| NCOA1 | PPARG | 111464 | 11027271 11500849 | FRET; Reconstituted Complex |
| NCOA1 | PPARG | 114200 | 11027271 11500849 | FRET; Reconstituted Complex |
| NCOA1 | RARA | 114200 | 9192892 10082574 10760302 17475621 | Affinity Capture-Western; FRET; Reconstituted Complex |
| NCOA1 | RARA | 111849 | 9192892 10082574 10760302 17475621 | Affinity Capture-Western; FRET; Reconstituted Complex |
| NCOA1 | RARB | 114200 | 8754792 | Reconstituted Complex |
| NCOA1 | RARB | 111850 | 8754792 | Reconstituted Complex |
| NCOA1 | RXRA | 114200 | 9171239 10082574 10935544 11027271 | Far Western; Reconstituted Complex; Two-hybrid |
| NCOA1 | RXRA | 112168 | 9171239 10082574 10935544 11027271 | Far Western; Reconstituted Complex; Two-hybrid |
| NCOA1 | SMARCA4 | 114200 | 11003650 | Phenotypic Enhancement |
| NCOA1 | SMARCA4 | 112481 | 11003650 | Phenotypic Enhancement |
| NCOA1 | SMARCE1 | 114200 | 12145209 16538531 | Reconstituted Complex |
| NCOA1 | SMARCE1 | 112489 | 12145209 16538531 | Reconstituted Complex |
| NCOA1 | TRIM21 | 114200 | 11971985 | Affinity Capture-MS |
| NCOA1 | TRIM21 | 112615 | 11971985 | Affinity Capture-MS |
| NCOA1 | STAT3 | 114200 | 11773079 17471507 | Affinity Capture-Western; Reconstituted Complex |
| NCOA1 | STAT3 | 112651 | 11773079 17471507 | Affinity Capture-Western; Reconstituted Complex |
| NCOA1 | STAT5A | 114200 | 12954634 | Affinity Capture-Western |
| NCOA1 | STAT5A | 112653 | 12954634 | Affinity Capture-Western |
| NCOA1 | STAT6 | 112655 | 11574547 12138096 14757047 14993689 15695802 18267973 | Affinity Capture-Western; Co-crystal Structure; Phenotypic Enhancement; Reconstituted Complex; Two-hybrid |
| NCOA1 | STAT6 | 114200 | 11574547 12138096 14757047 14993689 15695802 18267973 | Affinity Capture-Western; Co-crystal Structure; Phenotypic Enhancement; Reconstituted Complex; Two-hybrid |
| NCOA1 | TBP | 114200 | 8754792 | Reconstituted Complex |
| NCOA1 | TBP | 112771 | 8754792 | Reconstituted Complex |
| NCOA1 | TEAD1 | 114200 | 10934189 | Reconstituted Complex |
| NCOA1 | TEAD1 | 112862 | 10934189 | Reconstituted Complex |
| NCOA1 | THRA | 114200 | 9804773 9849963 10379889 11117530 | Affinity Capture-Western; Reconstituted Complex; Two-hybrid |
| NCOA1 | THRA | 112923 | 9804773 9849963 10379889 11117530 | Affinity Capture-Western; Reconstituted Complex; Two-hybrid |
| NCOA1 | THRB | 114200 | 9171239 9751500 | Phenotypic Enhancement; Protein-peptide; Reconstituted Complex |
| NCOA1 | THRB | 112924 | 9171239 9751500 | Phenotypic Enhancement; Protein-peptide; Reconstituted Complex |
| NCOA1 | NKX2-1 | 114200 | 11713256 | Reconstituted Complex |
| NCOA1 | NKX2-1 | 112936 | 11713256 | Reconstituted Complex |
| NCOA1 | VDR | 114200 | 10224118 11075811 11149488 17786964 | Reconstituted Complex |
| NCOA1 | VDR | 113264 | 10224118 11075811 11149488 17786964 | Reconstituted Complex |
| NCOA1 | NCOA3 | 114200 | 18267973 | Affinity Capture-Western |
| NCOA1 | NCOA3 | 113841 | 18267973 | Affinity Capture-Western |
| NCOA1 | TEAD2 | 114041 | 10934189 | Reconstituted Complex; Two-hybrid |
| NCOA1 | TEAD2 | 114200 | 10934189 | Reconstituted Complex; Two-hybrid |
| KAT2B | NCOA1 | 114200 | 9296499 9445475 | Affinity Capture-Western; Reconstituted Complex; Two-hybrid |
| KAT2B | NCOA1 | 114375 | 9296499 9445475 | Affinity Capture-Western; Reconstituted Complex; Two-hybrid |
| NCOA2 | NCOA1 | 114200 | 9751728 11971985 18267973 | Affinity Capture-MS; Affinity Capture-Western; Co-purification |
| NCOA2 | NCOA1 | 115761 | 9751728 11971985 18267973 | Affinity Capture-MS; Affinity Capture-Western; Co-purification |
| TRIP4 | NCOA1 | 114735 | 10454579 | Reconstituted Complex; Two-hybrid |
| TRIP4 | NCOA1 | 114200 | 10454579 | Reconstituted Complex; Two-hybrid |
| PPARGC1A | NCOA1 | 114200 | 10558993 | Affinity Capture-Western; Reconstituted Complex |
| PPARGC1A | NCOA1 | 116097 | 10558993 | Affinity Capture-Western; Reconstituted Complex |
| NR1H4 | NCOA1 | 114200 | 11136553 | Two-hybrid |
| NR1H4 | NCOA1 | 115296 | 11136553 | Two-hybrid |
| DDX17 | NCOA1 | 114200 | 11250900 | Co-fractionation; Phenotypic Enhancement; Phenotypic Suppression; Reconstituted Complex; Two-hybrid |
| DDX17 | NCOA1 | 115776 | 11250900 | Co-fractionation; Phenotypic Enhancement; Phenotypic Suppression; Reconstituted Complex; Two-hybrid |
| SRA1 | NCOA1 | 114200 | 11250900 | Phenotypic Enhancement |
| SRA1 | NCOA1 | 115329 | 11250900 | Phenotypic Enhancement |
| YWHAQ | NCOA1 | 116168 | 11266503 | Reconstituted Complex |
| YWHAQ | NCOA1 | 114200 | 11266503 | Reconstituted Complex |
| SNW1 | NCOA1 | 114200 | 11514567 | Phenotypic Enhancement; Phenotypic Suppression |
| SNW1 | NCOA1 | 116597 | 11514567 | Phenotypic Enhancement; Phenotypic Suppression |
| NCOR1 | NCOA1 | 114200 | 12569182 | Reconstituted Complex |
| NCOR1 | NCOA1 | 114973 | 12569182 | Reconstituted Complex |
| NR1I2 | NCOA1 | 114200 | 12909012 | Co-crystal Structure |
| NR1I2 | NCOA1 | 114380 | 12909012 | Co-crystal Structure |
| CARM1 | NCOA1 | 114200 | 18511550 | Reconstituted Complex |
| CARM1 | NCOA1 | 115760 | 18511550 | Reconstituted Complex |
| Gene Symbol | Interactant | Interaction ID | References | Description |
|---|---|---|---|---|
| ANKRD11 | NCOA1 | 183483 | 15184363 | ANCO-1 interacts with SRC-1. This interaction was modeled on a demonstrated interaction between human ANCO-1 and SRC-1 from an unspecified species. |
| NR1I3 | NCOA1 | 215388 | 15572376 | CAR interacts with an unspecified isoform of SRC-1. |
| No data |
- MGI ID: MGI:1276523
- Data Attributes: MGI curated and HomoloGene calculated
- ZFIN ID: ZDB-GENE-041001-175



AlzGene, PDGene and SZGene